FDA 510(k) FDA class 2 Substantially Equivalent 🇺🇸 United States

VITEK 2 AST-Streptococcus Cefuroxime (<=0.125 - >=8 µg/mL)

K Number: K260281 · Decision Mar 26, 2026
Classifications
1
FEI Numbers
23
Registration Numbers
23
Same Product Code
288
Applicant Total
3
Review Days
56

Basic Information

Device Name
VITEK 2 AST-Streptococcus Cefuroxime (<=0.125 - >=8 µg/mL)
K Number
K260281
Device Class
FDA class 2
Clearance Type
Traditional
Regulation Number
866.1645
Medical Specialty
Microbiology
Decision
Substantially Equivalent
Statement or Summary
Summary
Applicant
BIOMERIEUX
Date Received
January 29, 2026
Decision Date
March 26, 2026
Product Code
LON
Advisory Committee
Microbiology
Review Advisory Committee
MI
Third Party
N

Classifications

This FDA 510(k) entry is associated with 1 FDA classification via its product code.

Product Code Device Name
LON System, Test, Automated, Antimicrobial Susceptibility, Short Incubation

Similar 510(k) Clearances

Other 510(k) clearances with the same product code (LON), ordered by most recent decision date.

View all

Other Clearances by BIOMERIEUX

K Number Device Name
K141133 VIDAS H. pylori IgG, VIDAS 3, VIDAS Lyme IgG II, VIDAS RUB IgG, VIDAS TOXO M, VIDAS Human Chorionic Gonadotropin, VIDAS T4, VIDAS Testosterone, VIDAS TSH, and VIDAS D-Dimer Exclusion II
K102668 ETEST TOBRAMYCIN 0.016-256 UG/ML AND 0.064-1024 UG/ML